Biotechnology Assets, S.A. (BME:BST)
Spain flag Spain · Delayed Price · Currency is EUR
0.4130
+0.0210 (5.36%)
Oct 7, 2025, 4:41 PM CET

Biotechnology Assets Statistics

Total Valuation

BME:BST has a market cap or net worth of EUR 26.88 million. The enterprise value is 28.70 million.

Market Cap26.88M
Enterprise Value 28.70M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

BME:BST has 68.56 million shares outstanding. The number of shares has increased by 14.28% in one year.

Current Share Class 68.56M
Shares Outstanding 68.56M
Shares Change (YoY) +14.28%
Shares Change (QoQ) +7.05%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 9.06
PB Ratio 4.07
P/TBV Ratio 6.35
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -9.84
EV / Sales 9.68
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -327.55

Financial Position

The company has a current ratio of 0.81, with a Debt / Equity ratio of 0.32.

Current Ratio 0.81
Quick Ratio 0.81
Debt / Equity 0.32
Debt / EBITDA n/a
Debt / FCF -23.81
Interest Coverage -12.62

Financial Efficiency

Return on equity (ROE) is -44.40% and return on invested capital (ROIC) is -14.77%.

Return on Equity (ROE) -44.40%
Return on Assets (ROA) -9.11%
Return on Invested Capital (ROIC) -14.77%
Return on Capital Employed (ROCE) -22.36%
Revenue Per Employee 87,210
Profits Per Employee -85,803
Employee Count34
Asset Turnover 0.19
Inventory Turnover n/a

Taxes

Income Tax -139,119
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +34.25% in the last 52 weeks. The beta is 1.66, so BME:BST's price volatility has been higher than the market average.

Beta (5Y) 1.66
52-Week Price Change +34.25%
50-Day Moving Average 0.38
200-Day Moving Average 0.35
Relative Strength Index (RSI) 55.19
Average Volume (20 Days) 212,554

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BME:BST had revenue of EUR 2.97 million and -2.92 million in losses. Loss per share was -0.04.

Revenue2.97M
Gross Profit 2.62M
Operating Income -2.29M
Pretax Income -3.06M
Net Income -2.92M
EBITDA -1.29M
EBIT -2.29M
Loss Per Share -0.04
Full Income Statement

Balance Sheet

The company has 261,856 in cash and 2.09 million in debt, giving a net cash position of -1.82 million or -0.03 per share.

Cash & Cash Equivalents 261,856
Total Debt 2.09M
Net Cash -1.82M
Net Cash Per Share -0.03
Equity (Book Value) 6.61M
Book Value Per Share 0.10
Working Capital -851,300
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -73,854 and capital expenditures -13,765, giving a free cash flow of -87,619.

Operating Cash Flow -73,854
Capital Expenditures -13,765
Free Cash Flow -87,619
FCF Per Share -0.00
Full Cash Flow Statement

Margins

Gross margin is 88.19%, with operating and profit margins of -77.17% and -98.39%.

Gross Margin 88.19%
Operating Margin -77.17%
Pretax Margin -103.08%
Profit Margin -98.39%
EBITDA Margin -43.60%
EBIT Margin -77.17%
FCF Margin n/a

Dividends & Yields

BME:BST does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -14.28%
Shareholder Yield n/a
Earnings Yield -10.85%
FCF Yield -0.33%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BME:BST has an Altman Z-Score of -8.07 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -8.07
Piotroski F-Score 2